Antihypertensive and lipid lowering treatment in 70-74 year old individuals - Predictors for treatment and blood-pressure control: A population based survey. The Hordaland Health Study (HUSK)

被引:4
作者
Brekke M. [1 ]
Hunskaar S. [2 ]
Straand J. [1 ]
机构
[1] Section for General Practice, Department of General Practice and Community Health, University of Oslo
[2] Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen
关键词
Antihypertensive Drug; Antihypertensive Treatment; Lipid Lowering Drug; Statin User; Poor Blood Pressure Control;
D O I
10.1186/1471-2318-6-16
中图分类号
学科分类号
摘要
Background: In an elderly, community based population we aimed at investigating antihypertensive and lipid lowering medication use in relation to own and familiar cardiovascular morbidity and diabetes mellitus, as well as to lifestyle factors and general health. We also examined levels of blood pressure in untreated and treated residents, to investigate factors correlating with blood pressure control. Methods: A health survey carried out in 1997-9 in the county of Hordaland, Norway included a self-administered questionnaire mailed to 4 338 persons born in 1925-7. Drug use the day prior to filling in the questionnaire was reported. A health check-up was carried out, where their systolic and diastolic blood pressure (SBP and DBP), body mass index (BMI), and serum-cholesterol level were recorded. Results: One third of respondents used one or more antihypertensive drugs, while 13% of men and women were treated with a statin. Diabetes mellitus, own or relatives'cardiovascular disease, having quit smoking, physical inactivity, and overweight correlated with antihypertensive treatment. Mean blood pressure was lower in respondents not on treatment. Among those on treatment, 38% of men and 29% of women had reached a target BP-level of lower than 140/90 mm Hg. Own cardiovascular disease and a low BMI correlated with good BP-control. Conclusion: One third of 70-74 year old individuals living in the community used one or more antihypertensive drugs. Only around one third of those treated had reached a target BP-level of less than 140/90 mm Hg. Own cardiovascular disease and a low BMI correlated with good BP-control. © 2006 Brekke et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 32 条
[1]  
De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Et al., European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, Eur Heart J, 24, pp. 1601-1610, (2003)
[2]  
Chobanian A.V., Bakris G.L., Black H.R., The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC7 report, JAMA, 289, pp. 2560-2572, (2003)
[3]  
Atrerial hypertension andischemic heart disease. Preventive aspects, WHO Techn Rep Ser 1962
[4]  
No 231, (1962)
[5]  
Hetlevik I., The Role of Clinical Guidelines in Cardiovascular Risk Intervention in General Practice, (1999)
[6]  
Getz L., Kirkengen A.L., Hetlevik I., Romundstad S., Sigurdsson J.A., Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice, Scand J Prim Health Care, 22, pp. 202-208, (2004)
[7]  
Tonstad S., Rosvold E.O., Furu K., Skurtveit S., Undertreatment and overtreatment with statins: The Oslo Health Study 2000-2001, J Intern Med, 255, pp. 494-502, (2004)
[8]  
Tonstad S., Furu K., Rosvold E.O., Skurtveit S., Determinants of control of high blood pressure. The Oslo health study 2000-2001, Blood Pressure, 13, pp. 1-7, (2004)
[9]  
Helseundersøkelsen I Hordaland
[10]  
Guidelines for ATC Classification and DDD Assignment, (1998)